1. Boyce JD, Wilkie I, Harper M, et al. Genomic scale analysis of Pasteurella multocida gene expression during growth within the natural chicken host. Infect Immun 2002; 70(12): 6871-6879.
2. Peng Z, Liang W, Wang Y, et al. Experimental pathogenicity and complete genome characterization of a pig origin Pasteurella multocida serogroup F isolate HN07. Vet Microbiol 2017; 198: 23-33.
3. Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol Lett 2006; 265(1): 1-10.
4. Chen Q, Chen Z, Zhang Z, et al. Profiling chromatin accessibility responses in goat bronchial epithelial cells infected with Pasteurella multocida. Int J Mol Sci 2023; 24(2): 1312. doi: 10.3390/ijms24021312.
5. Hao J, Xie L, Yang T, et al. Naked-eye on-site detection platform for Pasteurella multocida based on the CRISPR-Cas12a system coupled with recombinase polymerase amplification. Talanta 2023; 225: 124220. doi: 10.1016/j.talanta.2022.124220.
6. Harper M, Boyce JD. The myriad properties of Pasteurella multocida lipopolysaccharide. Toxins 2017; 9(8): 254. doi: 10.3390/toxins9080254.
7. Malhotra S, Phan T. Pasteurella multocida bacteremia in a patient with septic arthritis. Infect Med (Beijing) 2022; 1(3): 221-223.
8. Michael GB, Kadlec K, Sweeney MT, et al. ICEPmu1, an integrative conjugative element (ICE) of Pasteurella multocida: analysis of the regions that comprise 12 antimicrobial resistance genes. J Antimicrob Chemother 2012; 67(1): 84-90.
9. López-Ochoa AJ, Sánchez-Alonso P, Vázquez-Cruz C, et al. Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis. Plasmid 2019; 103: 45-52.
10. San Millan A, Escudero JA, Gutierrez B, et al. Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids. Antimicrob Agents Chemother 2009; 53(8): 3399-3404.
11. Boy C, Lesage J, Alfenore S, et al. Study of plasmid-based expression level heterogeneity under plasmid-curing like conditions in Cupriavidus necator. J Biotechnol 2022; 345: 17-29.
12. Ujvári B, Makrai L, Magyar T. Characterisation of a multiresistant Pasteurella multocida strain isolated from cattle. Acta Vet Hung 2018; 66(1): 12-19.
13. Lang Y, Li Y, Jasperson D, et al. Identification and evaluation of antivirals for Rift Valley fever virus. Vet
Microbiol 2019; 230: 110-116.
14. San Millan A. Evolution of plasmid-mediated antibiotic resistance in the clinical context. Trends Microbiol 2018; 26(12): 978-985.
15. Imre A, Olasz F, Kiss J, et al. A novel transposon-based method for elimination of large bacterial plasmids. Plasmid 2006; 55(3): 235-241.
16. Letchumanan V, Chan KG, Lee LH. An insight of traditional plasmid curing in Vibrio species. Front Microbiol 2015; 6: 735. doi: 10.3389/fmicb. 2015.00735.
17. Song N, Xu J, Li Z, et al. Curing a large endogenous plasmid by single substitution of a partitioning gene. Plasmid 2015; 82: 10-16.
18. Trevors JT. Plasmid curing in bacteria. FEMS Microbiol Lett 1986; 32(3-4), 149-157.
19. Munir R, Farooq U, Badar N, et al. Restriction endonuclease analysis of Pasteurella multocida field isolates by Hha I. Pakistan Vet J 2006; 26(2): 80-84.
20. Ferreira TS; Felizardo MR, de Gobbi DD; et al. Antimicrobial resistance and virulence gene profiles in P. multocida strains isolated from cats. Braz J Microbiol 2015; 46(1): 271-277.
21. Ewers C, Lübke-Becker A, Bethe A, et al. Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status. Vet Microbiol 2006; 114(3-4): 304-317.
22. Ujvári B, Gantelet H, Magyar T. Development of a multiplex PCR assay for the detection of key genes associated with Pasteurella multocida subspecies. J Vet Diagn Invest 2022; 34(2): 319-322.
23. Bimboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979; 7(6): 1513-1523.
24. Hindler JA, Richter SS. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria: M45. 3rd ed. Wayne, USA: Clinical and Laboratory Standards Institute 2016.
25. Testing ECOAS. EUCAST clinical breakpoints. Basil, Switzerland: European Society of Clinical Microbiology and Infectious Diseases. Available at: https://www. eucast.org/bacteria/clinical-breakpoints-and-inter-pretation/clinical-breakpoint-tables/. Accessed July 07, 2026.
26. Prihandani SS, Noor SM, Wibawan IWT, et al. Polymerase chain reaction to confirm biochemically characterization method of Pasteurella multocida isolate from fatal cases of septicaemia epizootica in Nusa Tenggara Timur. IOP Conf Se.: Earth Environ Sci 2022; 976: 012046. doi: 0.1088/1755-1315/ 976/1/012046.
27. Arashima Y, Kumasaka K. Pasteurellosis as zoonosis. Inter Med 2005; 44(7): 692-693.
28. Liu W, Yang M, Xu Z, et al. Complete genome sequence of Pasteurella multocida HN06, a toxigenic strain of serogroup D. J Bacteriol 2012; 194(12): 3292-3293.
29. McGee JE, Bejcek BE. A cryptic plasmid from Pasteurella multocida has a predicted protein nearly identical to a transport protein from Actinobacillus actinomycetemcomitans. Plasmid 2001; 46(1): 60-64.
30. Tang X, Zhao Z, Hu J, et al. Isolation, antimicrobial resistance, and virulence genes of Pasteurella multocida strains from swine in China. J Clin Microbiol 2009; 47(4): 951-958.
31. Okoye EL, Kemakolam C, Ugwuoji ET, et al. Multidrug resistance tracing by plasmid profile analysis and the curing of bacteria from different clinical specimens. Adv Gut Microbiome Res 2022; 2022: 3170342. doi: 10.1155/2022/3170342.
32. Buckner MMC, Ciusa ML, Piddock LJV. Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing. FEMS Microbiol Rev 2018; 42(6): 781-804.
33. Gong Q, Qu N, Niu M, et al. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida. Vet Immunol Immunopathol 2013; 152(3-4): 317-324.
34. Tatum FM, Briggs RE. Construction of in-frame aroA deletion mutants of Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus by using a new temperature-sensitive plasmid. Appl Environ Microbiol 2005; 71(11): 7196-7202.
35. Chung JY, Wilkie I, Boyce JD, et al. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A. Infect Immun 2001; 69(4): 2487-2492.
36. Harper M, Cox AD, St Michael F, et al. A heptosyl-transferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence. Infect Immun 2004; 72(6): 3436-3443.
37. Johnson CM, Grossman AD. Integrative and conjugative elements (ICEs): what they do and how they work. Annu Rev Genet 2015; 49: 577-601.
38. Caro L, Churchward G, Chandler M. Study of plasmid replication in vivo. Methods Microbiol 1984; (17): 97-122.
39. Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018; 555(7698): 623-628.
40. Alhamami T, Chowdhury PR, Gomes N, et al. First Emergence of resistance to macrolides and tetracycline identified in Mannheimia haemolytica and Pasteurella multocida isolates from beef feedlots in Australia. Microorganisms 2021; 9(6): 1322. doi: 10.3390/micro-organisms9061322.
41. Citron DM, Warren YA, Fernandez HT, et al. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol 2005; 43(5): 2485-2488.
